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Aims Some countries have a demography that makes it necessary to maintain relatively small pacemaker centres. We
wanted to assess the quality of pacemaker surgery in two such hospitals.
Methods
and results
Through patient records we gathered information on  535 consecutive primary pacemaker implantations in two
small pacemaker centres with 30 and 80 annual operations, respectively. All patients were followed for 3 years.
All complications documented in the patient records were registered. Furthermore, we performed a non-systematic
literature search comparing our data with reports from major centres published over the last 10 years.We found 72
complications in 64 (12.0%) of the patients, the most common being bleeding, lead failure, and pneumothorax. If
minor bleedings without any consequences for the patients are excluded, the number of complications was 46 in
40 patients (7.5%). We had to reoperate on 5.2% of the patients. There was no statistically signiﬁcant difference
in complication rates between the two hospitals. Education candidates generated statistically signiﬁcant more com-
plications than experienced doctors (13.7 vs. 7.1%, P , 0.05).
Conclusion There are no generally accepted norms of complication rates in pacemaker surgery. However, we found no indi-
cations that our centres have a rate of complications that is unacceptably high.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
In 2009, Scandinavian hospitals performed 11 608 primary pace-
maker implants.
1 Although the equipment is constantly being
improved, there are still a signiﬁcant number of patients experi-
encing complications after surgery. Although some countries
have come quite far in establishing national quality indices,
there is still a lack of robust international quality data that can
be used as the basis for the evaluation of own activity. The
main reason is that study design and deﬁnitions differ signiﬁcantly
from report to report. High-quality, prospective studies are rare,
and those available tend to have a design making them little
applicable for the evaluation of an ordinary, unselected pace-
maker practice.
Norwegian hospitals implanted 2333 pacemakers in 2009,
1 489
new implants per million inhabitants. We have 25 pacemaker
centres, each centre performed on average 93 new implants in
2009, ranging from  30 to 300.
The present study was performed to evaluate the quality of
pacemaker surgery in two smaller pacemaker centres in Northern
Norway. Our region has a scattered population and our hospitals
are relatively small. For the population, proximity to treatment is a
quality factor, but the loss of technical quality is a potential negative
result of decentralization.
We have retrospectively studied 535 consecutive primary
pacemaker implantations in one small- and one medium-
sized pacemaker centre and registered complications
discovered within the ﬁrst 3 years after initial surgery. Our
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Methods
The project was approved by the Norwegian Social Science Data Ser-
vices. Data were collected manually from patient records. This means
that all complications judged by healthcare professionals to be clinically
signiﬁcant were registered.
Hospitals
Sandnessjøen hospital is the smallest pacemaker centre in Northern
Norway, serving a population of 70 000 and performing an annual
average of 28 primary pacemaker implantations in the study period.
This is, however, not an accurate picture as the number of implan-
tations varied widely from year to year, depending on the availability
of staff. The hospital has 60 beds and two cardiologists. Nordland hos-
pital in Bodø is a 5 h drive further north and is the nearest larger hos-
pital. The air ambulance service is well established, but it has serious
limitations because of difﬁcult weather conditions.
Nordland hospital in Bodø serves a population of 170 000 and per-
formed between 80 and 90 primary pacemaker operations annually in
the study period. The hospital has 250 beds and six cardiologists.
All operations were done by a cardiologist or trainees under super-
vision. The proportion of operations performed by trainees was com-
parable in the two hospitals. The operations were done in standard
operating rooms. All patients received a single pre-operative dose of
dicloxacillin.
The patients had their ﬁrst follow-up after 3–4 months, thereafter
annually. Most patients were followed at the implanting centre,
except for a few patients who moved to another region during the
follow-up period. For these last patients, complete hospital records
were obtained to reveal any complications registered locally.
Study period
In order to achieve the same number of cases from the two hospitals,
the period of registration was longer in Sandnessjøen than in Bodø. In
Sandnessjøen, we evaluated patient records from a 10-year period
from 1 January 1997 to 31 December 2006. All patients were followed
up for 3 years, and the ﬁnal review of the medical records was done in
the spring of 2010. In Bodø, we examined the results of a 3-year period
in the middle of this decade—from 1 September 2000 to 31 August
2003. Patients from Bodø were also followed up for 3 years.
Deﬁnition of complications
Both in the collection of our data and in our literature review, we have
used the following deﬁnitions of complications, partly built on Pakari-
nen et al.
2 and Ellenbogen et al.
3 The deﬁnitions are aligned to make
the results more comparable to other publications.
Reoperation
Any situation in which it was necessary to do more than one surgical
intervention to make the pacing system work, or to correct an unac-
ceptable discomfort for the patient. Chest tubes for pneumothorax
are not included.
Bleeding
Any swelling of the pocket with clinical suspicion of haematoma. Any
external bleeding that required special attention from the medical staff.
Lead failure
Development of high pacing thresholds or sensing problems resulting
in the need to programme the device to a different pacing mode or the
need for reoperation.
3 Thus, the term lead failure does not necessarily
imply fracture or errors in production.
Pneumothorax
Absence of lung markings over the lung ﬁeld ipsilateral to the pace-
maker pocket assessed from the pre-discharge x-ray.
2 All such ﬁndings
are included, regardless of the need of a chest tube.
Heart perforation: Procedure-related pericardial effusion or pericar-
dial pain requiring prolonged post-operative surveillance or lead
repositioning.
2
Cardiac tamponade
Pericardial effusion causing haemodynamic compromise and requiring
drainage.
2
Device infection
Superﬁcial wound infection or device system infection, deﬁned as
pocket infection or fever, associated with positive blood cultures
without an infectious focus elsewhere.
2 We also include any perfor-
ation or near perforation even if there is no sign of infection.
Statistics
Differences in complication rates were analysed by means of GraphPad
Prism 5.0 for Windows. Level of signiﬁcance was calculated using the
Fisher Irwin’s test when the number of events was small and x
2 test
when the number was large. A two-tailed P value ,0.05 was con-
sidered statistically signiﬁcant.
Literature review
We have made a non-systematic literature search through PubMed for
the years 1998–2010. We found 14 studies that more or less
accurately render rates of adverse episodes in pacemaker surgery.
The material includes both multi-centre and single-centre studies.
In some of the studies complication rates or the number of leads is
speciﬁed as shares.
4–8 In such situations it has been necessary to
convert to absolute numbers for comparison. The results of our litera-
ture review are summarized in Table 1.
Results
During the study period, Sandnessjøen hospital had a total of 282
primary implantations, an average of 28 patients annually, while
Bodø had 253 primary implantations and an annual average of 84
operations. Eight hundred and ninety-four leads were implanted.
Sixteen (3.0%) of the operations were made with venous access
through the cephalic vein, the others had subclavian venous
access. Data for implant duration and ﬂuoroscopy times were
not available.
Patient characteristics are summarized in Table 2.
All patients were followed for 3 years, or until death. No
patients were lost from follow-up, and data have also been col-
lected if the patient moved or was transferred for follow-up else-
where. There were no statistically signiﬁcant differences in
complication rates or frequency of reoperations between the
two hospitals (Table 3).
No patients died during surgery. Twelve patients died during the
ﬁrst 30 days after implantation. One patient died from sudden
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Table 1 Our data compared with other studies published during the last 10 years
Haug
et al.
Pakarinen
(2010)
2
Wiegand
et al.
9a
Kiviniemi
(1999)
4
Tobin
(2000)
10
Villalba
et al.
11b
van Eck
et al.
6h
Møller
et al.
5
Wiegand
(2003)
7c
Ellenbogen
et al.
3d
Klug
et al.
12
Eberhardt
et al.
13b
Link
et al.
14c,f
Nery
et al.
8
Nowak
et al.
15g
Number of patients 535 567 3164 446 1332 2108 1198 5593 1214 2010 6319 1884 407 2417 17826
Lead
dysfunction
n 26 21 na 32 32 56 32 268 24 61 na
e 56 9 na 411
No. of
leads
894 865 na 547 2264 3078 2053 8993 1614 4020 171 2787 814 na 28760
% 2.9 2.4 5.9 1.4 1.8 1.6 4.8 1.5 1.5 2.0 1.1 1.4
Pneumothorax n 15 11 na 5 20 2 24 54 7 32 na 11 8 na 95
% 2.8 1.9 1.1 1.5 0.1 2.0 1.0 0.6 1.6 0.6 2.0 0,5
Infection n 4 11 9 12 na 4 6 15 4 4 91 na 2 24 20
% 0.7 1.9 0.3 2.7 0.2 0.5 0.3 0.3 0.2 1.4 0.5 1.0 0.1
Bleeding n 28 18 155 5 na 12 23 21 6 na 328 11 na na 128
% 5.2 3.2 4.9 1.1 0.6 1.9 0.4 0.5 5.2 0.6 0.7
Reop. n 28 52 na 50 na 20 na 340 51 93 175 85 18 na na
% 5.2 9.2 11.2 0.9 6.1 4.2 4.6 2.8 4.5 4.4
Type of study Ret Ret Ret Ret Pro Ret Pro Reg Ret Pro Pro Ret Pro Ret Reg
Observ. 36 3 3 27 0 51 0 na 63 33 12 64 18 na 0
Subcl. access 97 10 53 70 .95 15 90 47 51 na na 58 73 na 44.5
Lost (%) 0.0 0.0 0.0 7.3 0.0 na 0.0 1.0 0.0 0.0 14.5 0.0 na na 0.0
For lead dysfunction, the number of registered errors and total number of leads are listed. Percentage is calculated in relation to the total number of leads. For the rest, the proportion is calculated in relation to the number of patients. At the
bottom of the table we have listed the length of the observation period (in months) for each study. Observation period equal to 0 indicates that only complications during the initial admission are included. Proportion of patients with venous
access made through the subclavian vein (Subcl. access) is speciﬁed in percentage. Lost in the observation period speciﬁes the percentage of the originally included patients that disappeared during the observation period.
Ret, retrospective; Pro, prospective; Reg, registry study; Reop, re-operation; Observ, observation period; na, not available; Subcl, subclavin venous access.
aRetrospective study with a special focus on perioperative bleeding.
bRetrospective study designed to evaluate a pacemaker-implantation done as day-surgery.
cIncludes only complications that caused reoperation.
dPatients included in MOST study, designed for the evaluation of mode selections in patients with sinus node disease.
eNot possible to calculate due to inconsistent data in the article.
fPatients included in PASE study, designed to evaluate mode selection in elderly.
gRegistry study designed to study gender differences in complication frequency.
hExcerpt from FOLLOWPACE study, prospective, designed to assess the cost-effectiveness of routine follow-up visits in patients with pacemaker.
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2circulatory collapse the day after surgery. The patient was under
permanent monitoring as he died, and no arrhythmia was
observed. Autopsy did not reveal any exact cause of death.
Eleven patients died after discharge from hospital, one from cer-
ebral infarction, one from heart failure, two from malignant
arrhythmia, three from myocardial infarction, and three from infec-
tions not related to pacemaker implantation. One patient died
during cancer surgery.
We found 73 complications in 64 (12.0%) patients. There was
no statistically signiﬁcant difference in complication rate between
patients below and above the age of 80 years.
The frequency of the various complications is summarized in
Table 1.
We recorded bleeding in 28 patients. Only one patient needed
transfusion. The rest mainly consisted of minor haematomas,
without any consequence for the patient. If these are not
counted, the number of complications are 46 in 40 patients (7.5 %).
Reoperations
In our material, 28 (5.2%) of patients required reoperation. Of
these, 20 patients were reoperated for lead dislocation, and this
was the most common reason for surgical revision. Reoperations
themselves are not counted as complications, as the incident
that leads to the reoperation already is counted.
Bleeding
Pocket bleeding was observed in 5.2% of the patients and was thus
the most common complication. One patient needed blood trans-
fusion after bleeding; otherwise there were no serious bleedings.
No patients needed surgical revision for their haematomas, and
as far as we can see from the patient records, there were no pro-
longations of hospitalization or other consequences from the
bleedings. It is of interest to note that pocket haematoma was
not recorded in any of the patients who subsequently developed
infection.
Lead failure
No patient had failure of more than one lead. Lead failure occurred
in 4.9% of our patients and was the second most frequent compli-
cation. We implanted a total of 894 leads and found dysfunction in
26 (2.9 %). Of these, 20 patients were reoperated and six pace-
makers were reprogrammed to a less optimal pacing mode.
Twenty-ﬁve appeared during the ﬁrst 30 days after surgery and
one was discovered later.
Pneumothorax
Fifteen patients (2.8 %) had pneumothorax. Of these, eight patients
needed a chest tube. Venous access was via cephalic vein cutdown
in 16 patients (3.0 %). In the rest, venous access was done via sub-
clavian vein puncture. All cephalic vein cutdowns were done in
Sandnessjøen hospital.
Heart perforation and cardiac tamponade
We observed no patients with heart perforation or cardiac
tamponade.
Device infection
Four (0.7%) patients had infections related to pacemaker surgery.
In two patients the infection was discovered during the ﬁrst
30 days after surgery, and both these developed systemic infec-
tions. The last two started later than 30 days after surgery and
both were infections limited to the pocket.
Operator volume and experience
A total of eight doctors performed independent surgery during the
study period. Table 4 displays complication frequency and need for
reoperation in relation to operator volume. Three of the doctors
were fully qualiﬁed cardiologists, while the other ﬁve were trainees
in cardiology under supervision.
Education candidates operated 124 patients and generated 17
(13.7%) complications and 9 (7.3%) reoperations. The specialists
performed 411 operations and generated 29 (7.1%) complications,
................................................................................
Table 2 Patient characteristics, indication for
pacemaker, choice of pacing mode and venous access to
the heart
Total
number
n %
535
Age 0–40 6 1.1
41–60 45 8.4
61–80 281 52.5
81–90 176 32.9
.90 27 5.0
Female 237 44.3
Indication Atrioventricular block 206 38.5
Sick sinus syndrome 228 42.6
Atrial ﬁbrillation/ﬂutter and
bradycardia
77 14.4
Tachycardia 4 0.7
Other 20 3.7
Mode DDD 359 67.1
AAI 80 15.0
VVI 96 17.9
Venous access Subclavian 519 97.0
Cephalic 16 3.0
.............. ..................
................................................................................
Table 3 Assessment of complications and reoperations
in the two hospitals
Bodø Sandnessjøen P
No % No %
Number of patients 253 282
Lead dysfunction 11 4.3 15 5.3 0.69
Bleeding 1 0.4 0 0.0 0.47
Pneumothorax 10 4.0 5 1.8 0.9
Infection 3 1.2 1 0.4 0.35
Total number 25 9.9 21 7.4 0.36
Re-operations 12 4.7 16 5.7 0.70
Minor bleedings without any consequence to the patients are not included.
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for complication rate (P , 0.05), but not for reoperations
(P ¼ 0.26).
Discussion
Northern Norway has, due to long distances and difﬁcult transport
conditions, found it appropriate to retain a decentralized hospital
structure. This means that the number of certain medical pro-
cedures will be lower than what is recommended in guidelines
and what is usually performed in countries with a more concen-
trated population. It is possible that a low volume may result in
lower surgical quality. Such a loss of treatment quality may be
acceptable if the alternative centralization increases transport
time to the extent that this itself becomes a quality-reducing
factor. Nevertheless, it is important that the technical quality is
controlled so that measures can be taken if complication rates
become unacceptably high.
To obtain a sufﬁcient number of operations for comparison
from the smallest hospital, we had to go as far back as 1997.
Since then, there has been a huge development of pacing equip-
ment and technique. This makes interpretation of the data difﬁcult,
but many of the studies we are comparing us with have collected
data in the same period, and the conclusions should therefore be
durable.
Complications in device-surgery still are a relatively common
problem. In 1999, Kiviniemi et al.
4 reported complications in
13.2% of such patients and it seems that this number has not
changed substantially over the past decade. We found 12.0% and
Pakarinen et al.
2 found 12.2%.
We have compared our data with ﬁgures from the international
literature. The literature contains no standardized norms of accep-
table complication frequency in device-surgery. The problem with
such comparisons is, therefore, that the presumptions behind the
numbers in the studies can be very different.
The data referred to in our study were not collected with the
aim of reporting complications, and the number of operations is
fairly small. The populations included in the studies we are compar-
ing us with may vary, and the sampling methods may diverge. Thus,
statistical analysis on differences in complication rates between
various studies will in general not be appropriate.
Literature review
Our study is retrospective, and like most other similar works, we
have identiﬁed—through the hospital archive—all patients that
have received a pacemaker during the time period in question.
We have then extracted the relevant information from their hos-
pital records.
Prospective, dedicated studies are probably the trials best suited
to give a correct picture of the quality and frequency of compli-
cations. Such studies are rare. The prospective studies we have
found are all designed for a different purpose than to evaluate
complications in an unselected ordinary pacemaker practice.
Thus, patients, operators, or other conditions are selected in a
way that may affect the results.
The quality of registry studies depends on data reported from
the pacemaker centres. Møller et al.
5 included 8.5% of the patients
in their registry study in an audit and found that 16.0% of compli-
cations were not reported to the registry. On the other hand, van
Eck et al.
6 found no such deviations in a similar audit of 6.2% of the
patients in their prospective study. There is still a possibility that
this is a consistent phenomenon, both in registry studies and in
prospective multicentre studies.
Retrospective studies based on patient records will always be
unselected. High data quality still depends on the accuracy of
the patient records, and complications not documented in the
record represent a potential source of error. In addition,
the lack of pre-deﬁned data sampling, and the fact that our data
are rather old, also makes the interpretation difﬁcult. On the
other hand, our patient population has been very stable, and we
...............................................................................................................................................................................
Table 4 Activity and complication rate per doctor
Number of
operations
during study
period
Approximate number
of operations prior to
study period
Years
during
study
period
Average yearly
number of
operations
Number of
complications
% Number of
reoperations
%
Doctor 1 228 70 10 228 11 4.8 10 4.4
Doctor 2 133 60 3 44.3 11 8.3 5 3.8
Doctor 3 58 150 3 19.3 7 12.1 4 6.9
Doctor 4 47 25 3 15.7 6 12.8 1 2.1
Doctor 5 45 0 2 22.5 6 13.3 5 11.1
Doctor 6 20 0 1 20.0 4 20.0 2 10.0
Doctor 7 8 0 1 8.0 0 0.0 0 0.0
Doctor 8 4 0 1 4.0 1 25.0 1 25.0
Doctors 1 to 3 were fully qualiﬁed cardiologiststhroughout the period, while four to eight were under training.The numbers do not giveacomplete picture of the activity because
Doctors 1 to 3 also were responsible for supervising the trainees under their operations. In addition, some of them worked elsewhere in parts of the study period and thus had a
higher activity than stated in the table. All the experienced doctors had a considerable volume prior to the study period.
Minor haematomas without any consequence for the patient are not counted.
B. Haug et al. 1584have been able to follow every single patient for 3 years. We are
therefore conﬁdent that the outline of our complications is fairly
complete.
Complications in our data
Our study includes only primary pacemaker implantations. Other
studies include both new implantations and secondary operations,
such as upgrade procedures and generator replacements, which
are known to be associated with a slightly higher frequency of
pacemaker-related infections. Some studies also include
implantations of implantable cardioverter deﬁbrillators and
cardiac resynchronization devices, procedures which also lead to
more complications. Our rate of complications should, therefore,
be expected to be lower than studies containing more complex
procedures, i.e. that by Pakarinen et al.
2
Our complication rate does not appear to be unacceptably
high. Pakarinen et al.
2 have higher frequency of reoperations
compared to our data, while Møller et al.
5 found fewer
patients with pneumothorax. We used subclavian venous
access in 97.0% of the operations, which is the highest percen-
tage of all the studies we have reviewed. This probably explains
the difference in the incidence of pneumothorax. Rates of lead
failure and infections are the same in our material as in these
studies.
In the Nordland hospital, all patients were operated on with
venous access via subclavian puncture. In Sandnessjøen hospital
selected patients (e.g. patients suffering from emphysema and
patients using anticoagulation) were operated on with venous
access via cephalic vein cutdown. This may explain the observation
that Sandnessjøen has a somewhat lower rate of pneumothorax
(though not statistically signiﬁcant) than Nordland hospital.
Length of the observation period affects the number of compli-
cations, especially infections and lead failure. Ellenbogen et al.
3
speciﬁed their complication rate at 30 days to be 4.8%, after 90
days 5.5%, and after 3 years 7.5%. Wiegand et al.
7 found 54.9%
of complications in-hospital, and 68.6% during the ﬁrst 3 months
after the operation. Nery et al.
8 found infections up to 496 days
after the operation; the average time to recognition of infections
was 272 days after surgery.
Some studies specify lead failure as a percentage of the number
of patients.
2,10 Most studies, however, calculate the lead failure as a
proportion of implanted leads. We have only included studies in
our review in which it was possible to determine the number of
implanted leads. Comparing the proportion of leads that failed in
our study with the literature gives the impression that we have
unusually high rates of lead failure. Some studies
5,10 have
counted lead failure only when the lead is revised. Our data,
however, also include six patients who have not been reoperated
but managed by, e.g., reprogramming of the device. If we exclude
these patients from the comparison, our rate of lead failure
differs less from other reports.
Duration of observation probably also affects rate of lead failure.
Three of the ﬁve studies that have a lower frequency of lead failure
than ours only include complications registered in-hospital. Such
differences in the deﬁnition of complications are probably more
important in explaining observed variations than real differences
in the incidence of adverse events.
Ten studies contain details on haematomas and bleeding. The
studies that only include bleeding demanding reoperation ﬁnd an
incidence just below 1%.
4–7,11,13,15 Studies including all haemato-
mas ﬁnd an incidence around 5%.
9,12 Our deﬁnition ‘any swelling
of the pocket with clinical suspicion of haematoma’ is rather
wide and gives a certain room for individual discretion. Removing
minor bleedings from the material reduces our total complication
rate to 7.1 %.
The proportion of patients who needs more than one operation
to make the pacing system function properly is a good and robust
quality indicator. Both prospective and retrospective studies, and
probably also registry studies, will capture such additional pro-
cedures. Some authors have taken the consequence of this and
limited registration of complications to those that have caused
additional surgery.
7,13 If we adjust for differences in observation
time, such an approach could be used as the norm for quality in
device-surgery. The average percentage of reoperations in 10
studies (including ours) is 5.3%. However, the range is large and
the results difﬁcult to interpret because of variations in study
design and observation period.
Eberhardt et al.
13 ﬁnd an increased complication rate among
older patients. There was no such difference in our material, nor
in the other studies we have reviewed.
Frequency of complications in relation
to the operator’s experience
Our study shows, in accordance with other studies, higher compli-
cation rates after operations performed by doctors with little
experience compared with more experienced colleagues. At the
same time, the experienced doctors have presumably operated
on the most challenging patients, where one can assume that the
risk of complications is higher. This means that the real difference
in frequency of complications can be even greater.
Our doctors have nevertheless less experience than those in
other studies. In the study of Pakarinen et al.
2 four cardiologists
did 325 operations during 1 year, which on average provides
over 80 operations per year, twice as many as our most active
operators. All our experienced operators have had periods prior
to the study period with higher activity. This observation may
have several explanations, but the fact that our operators have
an acceptable complication rate may indicate that intensive training
over a period may compensate for less practice in periods of lower
activity.
The observed difference in complication rate between trainees
and fully educated personnel is not as large as reported in other
studies.
2 However, supervision may represent an additional strain
on a small and less experienced staff and thereby lead to a
larger all over complication rate.
Conclusion
There are no generally accepted standards regarding registration of
complications in device surgery. Therefore, it is difﬁcult to ﬁnd
good benchmarks for quality. In addition, the number of patients
in our study is too small to draw sturdy conclusions.
Pacemaker implantation in small hospitals 1585However, our way to organize the pacemaker service has
brought arrhythmologic and electrophysiologic knowledge to an
area with a scattered population and difﬁcult transportation con-
ditions. In this context we ﬁnd our pacemaker service acceptable.
The present study does not reveal any reasons to change practice.
Like other authors, we found a higher rate of complications in
operations performed by trainees. Small pacemaker centres may
be particularly exposed to this, and education should probably
be relocated to larger hospitals. In addition, many of our compli-
cations are related to subclavian vein access. We will consider
using cephalic cutdown to a greater extent.
Good control of complication rates is important. Some countries
have established national pacemaker registries, while others are in the
process. Such registries should be organized in a way that facilitates
comparison of complication rates between individual pacemaker
centres and between local and national or international data.
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